Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

245.80 +0.14 (+0.06%)
Official Closing Price Updated: 7:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,911,413
Open 245.60
Bid (Size) 242.40 (1)
Ask (Size) 245.79 (1)
Prev. Close 245.66
Today's Range 245.02 - 247.53
52wk Range 225.42 - 281.70
Shares Outstanding 722,200,000
Dividend Yield 0.44%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Insanely Cheap Stocks to Buy
The object is to buy low and sell high. 
Via The Motley Fool
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery
Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely. 
Via Benzinga

Performance

YTD
+6.96%
+6.96%
1 Month
+6.28%
+6.28%
3 Month
+0.69%
+0.69%
6 Month
-9.52%
-9.52%
1 Year
+5.49%
+5.49%

More News

Read More
Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade Applications
From Aldevron
Via Business Wire
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years
Via Benzinga
14 Analysts Have This To Say About Danaher
Via Benzinga
What the Options Market Tells Us About Danaher
Via Benzinga
5 High-Flying Stocks In Dan Loeb's Portfolio: Cinemark, Corpay, Amazon Lead
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What the Options Market Tells Us About Danaher
Via Benzinga
Peering Into Danaher's Recent Short Interest
Via Benzinga
Inquiry Into Danaher's Competitor Dynamics In Life Sciences Tools & Services Industry
Via Benzinga
A Look Into Danaher Inc's Price Over Earnings
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,600 Today
Via Benzinga
Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks.
Via The Motley Fool
Critical Insights From Danaher Analyst Ratings: What You Need To Know
Via Benzinga
Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating
Via Benzinga
A Closer Look at Danaher's Options Market Dynamics
Via Benzinga
Earnings Preview: Danaher
Via Benzinga
Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday?
Via Benzinga
Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.